1. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. (4th May 2018) Authors: Leuci, V.; Casucci, M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L. D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE OF CLINICAL TRIALS. (23rd June 2022) Authors: Martino, E. A.; Conticello, C.; Zamagni, E.; Pavone, V.; Palmieri, S.; Musso, M.; Tacchetti, P.; Mele, A.; Catlano, L.; Vigna, E.; Bruzzese, A.; Mendicino, F.; Botta, C.; Vincelli, D.; Farina, G.; Barone, M.; Cangialosi, C.; Mancuso, K.; Rizziello, I.; Rocchi, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P535: UPDATES FROM ITALIAN MULTICENTER REAL-LIFE EXPERIENCE ON CPX-351 THERAPY IN YOUNG PATIENTS (<60 YEARS OLD). (23rd June 2022) Authors: Garibaldi, B.; Franciosa, M.; Pilo, F.; Menotti, D.; Cardinali, V.; Brunetti, L.; Martino, E. A.; Vigna, E.; Tanasi, I.; Duminuco, A.; Maugeri, C.; Parisi, M. S.; Fiumara, P. F.; Mauro, E.; Gentile, M.; Martelli, M. P.; Capelli, D.; Romani, C.; Galimberti, S.; Palumbo, G. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P564: FINAL RESULTS OF THE QOLESS AZA-AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5-AZA FOR POST-REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS. (23rd June 2022) Authors: Oliva, E. N.; Salutari, P.; Di Raimondo, F.; Reda, G.; Capelli, D.; Iannì, G.; Tripepi, G.; Alati, C.; Mammì, C.; D'Errigo, M. G.; Niscola, P.; Selleri, C.; Musto, P.; Vigna, E.; Volpe, A.; Cascavilla, N.; Cannatà, M. C.; Mannina, D.; Candoni, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS. (23rd June 2022) Authors: Bruzzese, A.; Derudas, D.; Galli, M.; Martino, E. A.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangicavalli, S.; Farina, G.; Lombardo, A.; Brunori, M.; Rossi, E.; Antonioli, E.; Ria, R.; Zambello, R.; Di Renzo, N.; Mele, G.; Marcacci, G.; Pietrantuono, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exposure to body odours combined with the effect of mindfulness treatment in patients with depressive and social anxiety symptoms - A preliminary study. (1st June 2022) Authors: Vigna, E.; Carli, V.; Hadlaczky, G.; Wasserman, D. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. (4th May 2018) Authors: Leuci, V.; Casucci, G. M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L. D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗